Rockwell Medical (RMTI) Operating Leases (2019 - 2026)

Rockwell Medical has reported Operating Leases for 8 years, with the latest figure at $3.3 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Leases rose 15.5% year-over-year to $3.3 million; the trailing twelve-month figure through Mar 2026 stood at $3.3 million (up 15.5% YoY), and the FY2025 full-year result was $1.5 million, down 14.42% from the prior year.
• Operating Leases for Q1 2026 stood at $3.3 million, up from $1.5 million in the prior quarter.
• The five-year high for Operating Leases was $7.4 million in Q1 2022, with the low at $1.4 million in Q4 2023.
• Historically, Operating Leases has averaged $3.3 million across 5 years, with a median of $2.6 million in 2022.
• Annual changes were most pronounced in 2022 — Operating Leases surged 110.11% — and 2023, when it slumped 76.72%.
• Rockwell Medical's Operating Leases stood at $2.6 million in 2022, then plunged by 44.48% to $1.4 million in 2023, then increased by 18.56% to $1.7 million in 2024, then slipped by 14.42% to $1.5 million in 2025, then soared by 127.03% to $3.3 million in 2026.
• The last three Operating Leases figures came in at $3.3 million (Q1 2026), $1.5 million (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.